Event Graphs, conditional representations of stochastic relationships between discrete events, simulate disease dynamics. In this paper, we demonstrate how Event Graphs, at an appropriate abstraction level, also extend and organize scientific knowledge about diseases. They can identify promising treatment strategies and directions for further research and provide enough detail for testing combinations of new medicines and interventions. Event Graphs can be enriched to incorporate and validate data and test new theories to reflect an expanding dynamic scientific knowledge base and establish performance criteria for the economic viability of new treatments. To illustrate, an Event Graph is developed for mastitis, a costly dairy cattle disease, for which extensive scientific literature exists. With only a modest amount of imagination, the methodology presented here can be seen to apply modeling to any disease, human, plant, or animal. The Event Graph simulation presented here is currently being used in research and in a new veterinary epidemiology course. ᭧
INTRODUCTION
Managing the information explosion in the health sciences is increasingly challenging. Numerous new reports are being published daily, ranging from basic research findings to studies of the latest pharmaceutical products. Health science professionals are finding it increasingly difficult to assimilate this new knowledge. The objective of this paper is to demonstrate how discrete event simulations, represented as Event Graphs, can be designed to serve as an organized repository for scientific knowledge. We demonstrate how easily extensible Event Graphs capturing disease and intervention dynamics can be designed to permit inclusion of new knowledge on diseases and treatment strategies. Event Graphs also provide researchers with a working simulation model to perform experiments. To illustrate this methodology, an Event Graph is developed for mastitis, one of the most costly dairy cattle diseases, with an estimated $150 million annual cost in New York State alone-the equivalent of $115 per cow annually (1) . Additionally, there is a sufficiently large scientific knowledge base to demonstrate how easily an Event Graph can be developed to capture the essentials of a broad scientific knowledge base.
PROBLEM DESCRIPTION AND PRIOR RESEARCH
At the highest level of qualitative abstraction in modeling a disease, fundamental aggregate health states must be identified and a general conceptual model must be developed. Influence diagrams have been used to identify important variables and their relationships and to define outcomes (2) . However ultimately, influence diagrams relate to a particular individual or a fixed group of individuals similar to other decision-tree approaches. When investigating public health or population medicine, the cohort under study is often dynamic. The research questions are defined on the changing cohort and to a lesser extent on an individual's outcome.
At a finer level of detail, Markov chains permit quantitative analysis (3) . This method requires assigning transition probabilities between health states and models time in discrete steps. These transition probabilities can model known or unknown values for risk factors. Markov chains explicitly represent all attainable health states, as well as the relevant history of the cohort. As health states are refined or more risk factors are included, the size of the model can rapidly expand-this is known as the "curse of dimensionality."
Using the mastitis infection process as an example, a basic Markov chain model based on Sorarrain et al. (4) , with the minimal states of "Not infected," "Subclinical infection," and "Clinical infection," can be represented with the state-transition diagram in Fig. 1 . This model is limited to diseases where the number of days in a particular health state can be adequately modeled as having a geometric distribution-a sick patient gets well on a particular day. There is one fixed constant transition probability between each pair of states independent of how the system arrived at that state. Furthermore, as more disease risk factors or pathogens are included, or as the patient's history is added, new dimensions must be added to the state space. Using information from more recent studies (5) the model can be enriched to become a semi-Markov process with the state transition diagram in   FIG. 1 . Markov chain where P ij is the transition probability and the time in state must have a geometric distribution. Key: Clinical infection (c), Subclinical infection (s), and Not infected (n).
FIG. 2.
The semi-Markov process P ij is the transition probability and there is a general time in state T i . Key: Clinical infection (c), Subclinical infection (s), and Not infected (n).
Fig. 2 (6)
. This model's advantage over a Markov chain model is that it allows a more general random time in each health state. State changes are described by transition probabilities, and as the model is enriched there is still the problem of increasing dimensionality. Markov processes often have been used to model different aspects of HIV-AIDS epidemic (7).
EVENT GRAPHS
Discrete event systems have three elements: state variables, the events that change the value of these state variables, and the relationships between the events. An Event Graph organizes sets of these three system elements graphically so that they can be visualized and easily simulated. An Event Graph (8) is a directed graph (balls, called event vertices, connected by arrows, called edges) that represents the logical and temporal relationships between system events. The fundamental building block for an Event Graph is an edge that tells under what conditions and after how much of a time delay one event will cause another to occur. It is depicted in Fig. 3 Visual Event Graph modeling allows researchers to represent the relationships between elements in a dynamic and often-complex system. Each event contains   FIG. 3 . Basic element of an Event Graph edge with time delay. Interpreted as if the condition (i) is true at the instant event A occurs, then event B will be scheduled to occur after a delay of t time units and the values of the expression k will be passed to parameter j in event B.
mathematical expressions for changes in the values of state variables. Event graph modeling offers many of the visual advantages of decision trees and influence diagrams (2) . Event graph modeling provides more than just structure to complex problems; using random delays and state changes, it allows modeling uncertainty and is dynamic at both individual and population levels. Risk factors can be changed for individuals or for the population as a whole. In addition, Event Graphs can be simulated directly (9) .
The Event Graph for our model is shown in Fig. 4 . While Figs. 2 and 4 appear similar, the conceptual models they represent differ vastly. For example, without increasing the size of the graph, the model in Fig. 4 incorporates 23 different characteristics that may be changed in any event listed in Table 1 . In the enrichment of the basic disease model from a semi-Markov process to an Event Graph, the transition probabilities become conditions between events. This is accomplished by translating the probability to a condition statement. For example, let the probability that a cow becomes clinically infected be 0.20; for the condition statement this is U Յ 0.20, where U is a random number between 0.0 and 1.0. This condition occurs on the edge between Not infected and Clinically infected (Figs. 4 and 5 ). In general, edge conditions can depend on the values of any state variables.
A graph representation of a Markov chain or a semi-Markov process with this many state variables would be enormous-if each variable could take on only 2 values, the graph would have 2 23 ϭ 8,388,608 vertices instead of 3. The key is that the Event Graph represents changes in state variables, not the states themselves. These characteristics may include risk factors or historical information specific to each individual. Based on the value of these risk factors, the next change in health is generated. A second notable feature of the Event Graph is that each individual currently in the population is given an index which is then passed between events as an event parameter. The Event Graph can thus represent a population of any size without increasing the size of the graph. Our Event Graph is called a "transient entity" model since it focuses on events pertaining to members of the population who enter or exit the study cohort. Each individual (the transient entity) can experience only one event at a time. A previous attempt to model replacement of mastitic cows (10) considered only two basic health states (not infected and clinical Number of times cow has receive antibiotic therapy this lactation Next udder health event (may be same or different) Days until next event Immune response in milk (somatic cell count) of the previous day Random error associated with milk yield of the previous day Random error associated with fat yield of the previous day Random error associated with protein yield of the previous day Random error associated with immune response of the previous day infection) with fewer characteristics. That model required 6,821,724 unique states to be explicitly represented in a hierarchic Markov process (zero-probability transitions were removed). These authors found that due to great amount of computational time consumed by the hierarchic Markov process, it could not be expanded.
STUDIES INCORPORATED
We wish to use this simulation of mastitis as an example of the general concept of using discrete event simulations as an organized repository for a wealth of scientific knowledge. Mastitis can be caused by various types of bacteria, algae, and yeast. Currently, the simulation models intramammary infection caused by the most common contagious pathogens, Staphylococcus aureus and Streptococcus agalactiae, and two common categories of environmental pathogens (Streptococcus non-agalactiae and coagulase-negative staphylococci). The model could be easily extended to include more pathogens, which is discussed later. In order to capture the disease process, the life cycle of adult cows within a dairy herd must be modeled. Age and parturition structure, milk yield, prevalence, and ratio of pathogens are from a dataset of 164 Central New York herds enrolled in the New York State Diagnostic Laboratory Quality Milk Promotion Service between January, 1993, and March, 1995. Stochastic variables are generated from distributions found in the literature:
• logarithmic transformation of somatic cell count used as an indirect measure of the immune response to infection (11), • days between parturition and next pregnancy, random test-day herd effect, and cow effect for milk yield (12), • gestation length (13),
• days between the end of lactation and next parturition (14) , and • time of removal from the herd (15).
Test-day milk, fat, and protein solutions were used to generate individual cow lactation curves (16) with autoregression terms (17) . Milk yield was adjusted for somatic cells/ml (18) , fat yield was adjusted for somatic cells/ml (19) , and protein yield was adjusted for somatic cells/ml (20) . Immune response from a clinical infection is modeled (21) . Transition probabilities between mammary gland health states (5) were modified to include subclinical infection and to become event scheduling conditions. The pathogen-specific probability of lactating-cow antibiotic therapy cure and spontaneous recovery (22) is used to condition infected and notinfected events in the model. The pathogen-specific probability of nonlactating cow antibiotic therapy cure (23, 24) is used as conditions between clinical and not-infected events. Pathogen-specific decreases in the new infection risks were used to calculate conditions among not-infected, clinical, and subclinical infection. Removal from the herd is modeled for reasons other than mastitis (13) and for mastitis (25) . Further discussion of the above equations, distributions, and their validation experiments are in Allore et al. (26) .
EVENT GRAPH SIMULATION
The basic Event Graph of The model uses parameter estimates from logistic regression to describe the risk of developing a disease and then translates this into a logical condition. Logistic regression is appropriate when the outcome is dichotomous. In order to estimate the conditional mean E(YȊx n ), where Y is a dichotomous outcome, x n is a vector of explanatory variables, and errors are logistically distributed, the specific form to derive a probability of disease is
Hence the known risk factors of number of lactations, stage of lactation, withinherd milk yield level, and number of quarters infected in the current and previous lactations are used to quantify the risk of developing mastitis in the next time interval. Individuals are transient entities moving through the model and carrying with them descriptive state variables which may be updated with each event. These state variables represent the system memory and risk factors for disease or removal from the herd. For example, lactation number is an endogenous risk factor that each cow updates (in this case increases) at each parturition and is used for calculating infection probabilities. Other risk factors are exogenous, such as season, and are applied to all cows.
Unlike semi-Markov process or Markov chain models, Event Graph simulations can have different individuals experiencing the same event at the same time. Individuals are identified with an index passed to each event as a parameter; this identifies the individual to which the event pertains. Therefore, a unique vertex is not created for each individual or even for each type of individual. For example, a first-lactation cow 100 days after parturition that had one previous infection could be scheduled for the same not-infected event as a fifth-lactation cow that has just calved without an infection in the nonlactating period. The Event Graph in Fig. 5 does not explicitly show how many individuals are in an event, as one might be accustomed to, say, in reading in a Petri net, but rather it needs only a description of the event that all members may be experiencing.
MODEL FLOW
The overall model logic, conditions, and time delays between events are as in Fig. 5 . The following events comprise the simulation. Event intervals, probability distributions, and state variable values are based on the state of knowledge from the literature. The simulation is an "open" model and hence is completely adaptable: event timing, probability distributions, and variable values, as well as the addition or deletion of events, are easily incorporated.
Create Individual Event
Individuals (here, cows) are created and are randomly assigned the characteristics of the cohort. The initialization process used here allows the initial sample population to give birth approximately uniformly throughout the calendar year with previous disease history and probability of infection at parturition. This greatly reduces the simulation initialization "warm-up" time. Generically, characteristics are assigned to each simulated individual in the population being modeled. Characteristics would include known and hypothesized risk factors, as well as outcome variables of interest (i.e., age for longevity studies).
Stage of Life Events
The Parturition event assigns values to state variables that describe the upcoming lactation and in which mammary gland health event (Not infected, Subclinical or Clinical) the lactation commences. Generically, this event represents an individual's entry to a different stage of life where characteristics might change their values, for example, the onset of puberty or menopause.
In the End Lactation event, individuals are evaluated as to whether they are removed from the sample population for disease or for other reasons. Removed individuals would immediately leave the sample population and a replacement would be scheduled to join the sample population (Replace event). If the individual is not removed, she is assigned to go to the Parturition event after a delay representing days nonlactating. The mammary gland infection status at parturition is determined based on mammary gland health at the end of lactation and the pathogenspecific probabilities in the user supplied data. These data contain the probability of a cure from antibiotic therapy or spontaneous recovery. This data is converted into a condition that is applied to the edge between End Lactation and Parturition in Fig. 5 . Generically, this event signifies the end of one stage and the initiation of another with possibly different risk factors or treatments.
Health Events
Modeled risk factors associated with changes in health events have been described and compared to published models (27) and validated (26) . The probability of exposure to disease-causing pathogens is included when determining the conditions between Not infected to either Subclinical or Clinical infection events. Generically, each individual has a probability of changing health event depending on their risk factors, immune status, and exposure. Within a discrete event simulation these probabilities are represented as conditions or logical Boolean statements. Hence, there might be more than one condition that allows individuals to change health events (for example, antibiotic therapy and susceptible pathogen or spontaneous recovery).
Upon entering a new health event, the health event in the next time period is determined; this could be the same or a different health event. If the individual has just entered an infected event for the first time, a pathogen is stochastically assigned based upon the proportion of each pathogen-specific infection currently in the sample population, accounting for exposure to contagious and environmental pathogens. Each infection is assigned a duration from a probability distribution. Generically, when a new health event is entered, all the state variables are updated (for example, temperature and leukocyte counts). The conditions are then evaluated, and the next health event is scheduled after a time delay (for example, schedule subacute after 12 h).
Not-infected event. In addition to the health event description above, to model a prevention program the probability of exposure to disease-causing pathogens is adjusted for any decrease in new infection risk associated with the prevention program. This decreased infection risk is reflected by the conditions between notinfected and infected events.
Subclinical event. In addition to the health event description above, if the individual arrives from the Clinical event, the same pathogen is kept. Conditions from the Subclinical event are not directly affected either by prevention programs (because the individual is already infected) or by antibiotic therapy (which might only apply to clinical infection); estimates of the probability of spontaneous recovery from subclinical infection are used to evaluated the condition between the Subclinical event to the Not-infected event. Subclinical infection can also increase in severity and become clinical. This is represented by the edge between Subclinical infection and Clinical infection (Figs. 4 and 5) . Furthermore, the model includes the fact that some pathogens have a higher probability of becoming more severe.
Clinical event. In addition to the health event description above, the same pathogen is kept if the individual is already subclinically infected. The condition between the Clinical event and the Not-infected event accounts for spontaneous recovery and, if used, antibiotic therapy. When antibiotic therapy is used, the probability that a clinical infection regresses to subclinical should be adjusted, if there is reason to believe that antibiotic therapy might also reduce symptoms in cases it does not cure.
Cohort Change Events
Replace is similar to the Create Individual event, except all new individuals will give birth for the first time within 30 days. Generically, this event allows new individuals to enter the simulated population. In the example, the sample population size is maintained; however, individuals can enter at any desired rate from any distribution. Hence with both the End Lactation event above and the Replace event, death and birth processes are modeled.
Simulation Events
While not technically part of the Event Graph model, the Initialize event is needed to initialize all variables and read input files for running a simulation created from the event graph using SIGMA. It is executed once at the start of a simulation run.
The Statistics event writes to an output file daily any traced state variables, for example, number of individuals in each health event, number of individuals that received antibiotic therapy, and number of individuals removed for disease and for reasons other than disease.
VALIDATION AND EXPERIMENTATION
The Event Graph simulation was validated against a separate dataset of 4140 monthly and 345 yearly test-day production and inventory records collect by Northeast Dairy Herd Improvement Association between January, 1989, and December, 1994 , where agreement between the model and data was excellent. The validation ( Table 2 ) and sensitivity analyses on input parameters have been described elsewhere (26) . Subsequent experimentation focused on herds with high prevalence of mastitis that produced milk above the threshold of proposed milk quality standard (28, 29) . Mastitis control strategies (prevention, lactating-cow antibiotic therapy, dry-cow antibiotic therapy, and all possible combinations of these) were investigated to find which if any would meet the new milk quality threshold without incurring a violation of the milk quality standard. Table 3 shows occurrences of milk quality measures that were equal to or greater than the proposed a Modified from Allore et al. (28) . b P denotes prevention due to milking time hygiene; AB denotes antibiotic therapeutics administered during lactation; NLAB denotes antibiotic therapeutics administered during the nonlactation period. milk quality standard as affected by strategies used to control mastitis over the simulated 24-month study period.
Partial budgeting was used to calculate the economic effect of these mastitis control strategies in poor milk quality herds (30) . Partial budget calculations were based on the mastitis control strategy's change from the mean of the control herds' gross revenue from milk, fat, and protein yields and the number of cows removed under a fixed mastitis removal criteria. Discounted annual benefit (measured in $/ cow/year) estimated the break-even price of each mastitis control strategy. Strategies that included both prevention and antibiotics used in the nonlactating period resulted (by inspection) in the highest discounted annual benefit for both the herds primarily infected with high levels of contagious pathogens and the herds that were free of Streptococcus agalactiae. For the herds that did not have IMI caused by Streptococcus agalactiae or Staphylococcus aureus, the strategies that included a vaccination for mastitis caused by Escherichia coli dominated those that did not include such a vaccination (Table 4) .
TESTING FUTURE DISEASE CONTROL PRODUCTS OR PROCEDURES
Banks and Norman (31) cite several advantages of nontraditional uses of simulations, and their usefulness as an organized repository of scientific knowledge should be added. To our knowledge, simulation has never been intentionally used in this manner although it has been used extensively for studying diseases. Hence the intent of our use of simulation and design of a generally extensible model is different. The extensible methodology of Event Graphs allows for detecting areas where the science base is weak or missing. This is done by hypothesizing uncertain relationships or effects and adding them to the event graph modeled with stochastic elements (either as state variables or conditions). This, in turn, permits exploration of how sensitive the model is to unknown elements and can direct future research. For example, the probability that a subclinical infection worsens in severity has not been extensively studied; hence the model can be used to test how sensitive the model is to changes in parameter estimates for this transition. If the model is sensitive then further clinical research in this area should be undertaken.
Simulation models constructed from Event Graphs are "open" models. Like other simulations, input parameters and data can be specific to the needs of their research project using current knowledge. However, unlike in many simulations, new state variables and events can be added to the model. Events and variables can also be removed without changing the model dynamics, by simply checking which edge conditions they might effect. This allows for testing of undeveloped products or different procedures without altering the core programming of the simulation.
Adding new knowledge to the Event Graph simulation. As contagious pathogens are controlled, the incidence of infection caused by environmental pathogens increases. To demonstrate how new knowledge about a pathogen could be added to the model, we will describe the case of adding Escherichia coli. The information needed to model the probability of contracting an infection caused by Escherichia coli is risk factors, distribution of the duration of infection, and how it would change state variables describing the individual's characteristics (i.e., damage to the mammary tissue that might reduce milk yield). Also needed is the probability that the infection will be clinical. Additionally, the duration of the infection is incorporated as the time until the next event. Finally, the immune response to the infection is added. All of these changes do not change the Event Graph (Fig. 5) .
Adding new risk factors to the Event Graph simulation. The first example adds a permanent endogenous risk factor, race (here, breed). This is easily accomplished by adding one more characteristic (state variable) to the individual. Then conditions that would be affected by this additional risk factor are updated. The second example is an exogenous risk factor, housing type. There are two ways to add this risk factor. If there is more than one type of housing, then an individual can be assigned a housing type, as done above. However, if the population has only one type of housing, instead of the addition of a characteristic to the individual, a global variable would be created. Again, all affected equations would be updated, and this change does not change the Event Graph (Fig. 5) .
Other experiments that could be run, and their model modifications, include:
• If a vaccine were to be investigated, the user would enter the projected decreases in new infection risk, and would possibly change the proportion of clinical infection that regresses to subclinical and modify the probability of spontaneous recovery.
• If a new antibiotic therapy were to be tested, then the probability of a cure would be changed and pathogen mutation probabilities would be added.
• If a different region were of interest, then the seasonal effects would be changed.
• If environmental pathogen dynamics or a mix of contagious and environmental pathogens is of interest, changing the initial pathogen ratios is possible.
The length of the simulation run, the time at which the treatment is employed, population size, birth, and death are all initially set by the user. If an epidemiologist wanted to study the passage of individuals, pathogen incidence or prevalence, or milk or component losses associated with specific pathogens, the model could provide such output. It is only a matter of choosing which events and which state variables to trace.
CONCLUSION AND FUTURE RESEARCH
Event Graph representations of simulation models can easily be enriched to represent new ideas and knowledge, and as such they offer a mechanism for structuring a disease knowledge base in health science. An Event Graph computer simulation, as presented here, is an excellent repository for scientific knowledge about disease processes and strategies for their control. This general concept was refined to focus on disease knowledge. Specifically, easily extensible models of disease and intervention dynamics were designed to permit inclusion of new knowledge on disease processes and treatment strategies. Furthermore, the paper explored the evolution in disease modeling from a Markov chain model to a semi-Markov process and finally to a simulation Event Graph. The simulation incorporates system memory without enlarging the visual representation or dimensionality of the graph. At its simplest level, an Event Graph replaces the transition probabilities with conditions, and it changes the time in a state to the delay between changes in states. Most importantly, like systems of differential equations that represent continuous dynamic systems, Event Graphs focus on the changes in system state rather than the values of the state variables. Because of this innovation, we may now model disease processes that were not possible to model in the past due to the size of the state description and computational limitations. Other health professionals, particularly HIV/AIDS, researchers should consider Event Graph representations of simulation models as a repository for the ever-increasing scientific knowledge in this area. Moreover, the simulation is a flexible methodology for the study of the epidemiology of HIV/AIDS spread and control strategies.
Using this methodology, another discrete event simulation model that focuses on major production diseases (mastitis, parturient paresis, ketosis, left-displaced abomasum, dystocia, retained placenta, metritis, cystic ovaries, abortion, and embryonic death) in the dairy population is being developed (32) . This new simulation presents a breakthrough for veterinary epidemiologists because of the computational limitations of using Markov chains or semi-Markov processes in the past did not allow the modeling of such complex, albeit more realistic, systems. Moreover, this new simulation is an organized repository of knowledge on 10 major diseases and their risk factors and interactions, as well as milk production, composition, and quality. This simulation allows for investigating milk quality, antibiotic residues in milk, and the impact of biotechnology on the milk supply, and it addresses economic considerations of preventive health strategies, such as biotechnology, vaccination, and therapy. Economic values associated with each of the above interventions and diseases are to be included in cost-benefit analyses. Resultant answers are useful to pharmaceutical companies, government programs, agribusinesses, veterinarians, dairy producers, and the research community.
